When women are diagnosed with PMOS, Polyendocrine Metabolic Ovarian Syndrome (the condition previously known as PCOS or polycystic ovary syndrome), the conversation often focuses on the most visible symptoms: irregular periods, acne, unwanted hair growth, and difficulty with weight management. These are real and important concerns. But for many women, the most clinically significant aspect of PMOS is something that produces no visible symptoms at all: insulin resistance. Understanding this connection is not just academic. It shapes every aspect of PMOS management and has direct implications for long-term health well beyond the reproductive years. At Tidewater Physicians for Women, this is a conversation we believe every woman with PMOS deserves to have.
First: Why the Name Changed
The shift from PCOS to PMOS reflects a more accurate understanding of the condition. The old name centered on ovarian cysts, which are neither present in all women with the condition nor the most important feature of it. Polyendocrine Metabolic Ovarian Syndrome better captures the systemic, multi-hormonal nature of the disorder, with “metabolic” specifically acknowledging the insulin resistance and cardiovascular risk factors that are central to the condition for a large proportion of women who carry this diagnosis.
What Insulin Resistance Actually Means
Insulin is the hormone responsible for signaling cells to absorb glucose from the bloodstream for use as energy. In a healthy metabolic state, cells respond efficiently to this signal. In insulin resistance, the cells become less responsive. The pancreas compensates by producing more insulin, which keeps blood glucose levels in a normal range for a time, but at the cost of chronically elevated insulin levels circulating throughout the body.
Those elevated insulin levels have direct effects on the ovaries. Insulin stimulates the ovaries to produce more androgens, the male-type hormones that, in excess, are responsible for many of the hallmark PMOS symptoms: acne, hirsutism (excess hair growth), hair thinning on the scalp, and disruption of ovulation. Insulin also acts on the pituitary gland in ways that further amplify androgen production. The result is a reinforcing hormonal cycle in which insulin resistance worsens androgen excess, which disrupts ovulation, which leads to irregular periods, all while the metabolic disruption continues in the background.
How Common Is Insulin Resistance in PMOS?
Studies suggest that somewhere between 50 and 80 percent of women with PMOS have measurable insulin resistance, even those who are not overweight or obese. This is an important point that often surprises women: insulin resistance in PMOS is not simply a consequence of excess weight. It can be present in lean women as well, driven by the underlying hormonal disruptions of the condition rather than body composition alone. This means that a normal body mass index does not rule out metabolically significant insulin resistance.
The Long-Term Metabolic Stakes
Because insulin resistance is present and often unaddressed for years or even decades, the metabolic consequences of PMOS accumulate over time. Women with PMOS have substantially elevated risk of developing type 2 diabetes compared to women without the condition. They also have higher rates of dyslipidemia (abnormal cholesterol and triglyceride levels), high blood pressure, and cardiovascular disease. These are not peripheral concerns; they represent some of the most common causes of morbidity and mortality in women, and they are directly linked to the insulin resistance that underlies PMOS.
This is one of the primary reasons why the new name, Polyendocrine Metabolic Ovarian Syndrome, is a meaningful improvement. It signals to both patients and providers that metabolic health is not a side issue in PMOS. It is a central feature that requires ongoing attention and management.
Testing for Insulin Resistance
Standard fasting blood glucose tests often appear normal in women with PMOS-related insulin resistance, because the compensatory insulin production is keeping glucose in a normal range. More sensitive measures include fasting insulin levels, a fasting glucose-to-insulin ratio, or a two-hour glucose tolerance test with insulin levels measured at intervals. If you have a PMOS diagnosis and have not had a formal metabolic assessment, this is worth discussing with your provider at your next visit.
What Addresses Insulin Resistance in PMOS?
Dietary changes: Eating patterns that reduce insulin spikes are foundational. This generally means reducing refined carbohydrates and added sugars, increasing dietary fiber, emphasizing lean protein and healthy fats, and minimizing ultra-processed foods. Mediterranean-style eating patterns have the strongest evidence base for women with PMOS.
Regular physical activity: Both aerobic exercise and resistance training improve insulin sensitivity. Even moderate amounts of regular movement produce measurable improvements in insulin response and downstream hormonal effects.
Metformin: This medication, originally developed for type 2 diabetes, directly improves insulin sensitivity and is one of the most widely used and evidence-supported medications for PMOS management. It can improve menstrual regularity, reduce androgen levels, and lower long-term metabolic risk.
Weight management support: For women with PMOS and overweight or obesity, even modest weight loss, in the range of 5 to 10 percent of body weight, can produce significant improvements in insulin sensitivity and PMOS symptoms. This is not always easy given the biological hurdles PMOS creates, but it remains one of the most effective interventions available.
Managing PMOS With the Full Picture in Mind
Effective PMOS management requires treating the whole condition, not just its most visible symptoms. At Tidewater Physicians for Women, our gynecology and women’s health teams are experienced in evaluating and managing PMOS in its full complexity, including the metabolic dimension. If you have a PMOS diagnosis and have not had a recent metabolic assessment, or if you are experiencing symptoms that may suggest PMOS and have not yet been evaluated, we encourage you to schedule an appointment at our Virginia Beach or Norfolk offices. You can also reach us at (757) 461-3890.
